Results 161 to 170 of about 177,264 (261)

4-Amino-7,8-dihydro-1,6-naphthyridin-5(6H)-ones as Inhaled Phosphodiesterase Type 4 (PDE4) Inhibitors: Structural Biology and Structure–Activity Relationships

, 2018
Richard S. Roberts, Sara Sevilla, Manel Ferrer, Joan Taltavull, Begoña Hernández, Vı́ctor Segarra, Jordi Gràcia, Martin D. Lehner, Amadeu Gavaldà, Míriam Andrés, Judit Cabedo, Dolors Vilella, Peter Eichhorn, Elena Calama, Carla Carcasona, Montserrat Miralpeix   +15 more
openalex   +1 more source

Effect of phosphodiesterase type 5 inhibitors on surgical outcome of ventricular septal defect and pulmonary hypertension patients. [PDF]

Egypt Heart J
Shams KA, Ellahony DM, Halima AF, Elzayat RS.   +3 more
europepmc   +1 more source

Effects of phosphodiesterase type 5 inhibitor and alpha-1A/D adrenoceptor antagonist on bladder remodeling in rats with spinal cord injury

, 2019
Katsumi Kadekawa, Kimio Sugaya
openalex   +2 more sources

The Effect of Phosphodiesterase Type 5 Inhibitors on the Development of Retinopathy of Prematurity in Imam Khomeini Hospital's, Ahvaz, Iran Preterm Infants: A Randomized Clinical Trial

, 2019
Masoud Dehdashtian, Mostafa Feghhi, Mohammad Reza Aramesh, Arash Malakian, Mohammadreza Abbaspour, Seyed Mohammad Hassan Altayeb, Ali Khosrevi   +6 more
openalex   +2 more sources

Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy? [PDF]

J Urol
Flores JM, Vertosick E, Jenkins LC, Cooper J, Benfante N, Sjoberg D, Vickers AJ, Eastham JA, Laudone VP, Scardino PT, Nelson CJ, Mulhall JP.   +11 more
europepmc   +1 more source

Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology. [PDF]

Clin Immunol, 2020
Dal Moro F, Livi U.
europepmc   +1 more source

Analysis of Phosphodiesterase Type 5 Inhibitors and Analogues as Adulterants in Herbal Dietary Food Supplements in Saudi Market Using Green UPLC-MS/MS Method: Assessment of the Greenness and Whiteness Profiles

Ahmed Mostafa
openalex   +1 more source

AOAC SMPR 2014.010: Identification of Phosphodiesterase Type 5 (PDE5) Inhibitors in Dietary Ingredients and Supplements

, 2015

openalex   +1 more source

Phosphodiesterase type 5 inhibitors related hearing impairment: a real world study based on the FDA adverse event reporting system. [PDF]

Sci Rep
Zhang X, Xia L, Yang Q, Tang P.
europepmc   +1 more source

Efficacy and safety of short- and long-term, regular and on-demand regimens of phosphodiesterase type 5 inhibitors in treating erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis

, 2017
D Tian, X Wang, Huan Zong, Y Zhang
openalex   +1 more source